| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/01/2012 | CN102335114A Stable ibuprofen arginine injection and preparation method thereof |
| 02/01/2012 | CN102335113A Clindamycin phosphate vaginal sustained-release gel and its preparation method |
| 02/01/2012 | CN102335095A Manufacturing technology of d-limonene hard capsules |
| 02/01/2012 | CN102010488B 一种温敏性可降解微水凝胶及其制备和应用 Temperature and sensitive micro-degradable hydrogel and its preparation and application |
| 02/01/2012 | CN101966147B 布洛芬注射液组合物及其制备方法 Ibuprofen Injection composition and its preparation method |
| 02/01/2012 | CN101961316B 一种lid-peg-plga缓释纳米微球及其制备方法 One kind of lid-peg-plga sustained release nanospheres and its preparation method |
| 02/01/2012 | CN101926771B 一种酰化支链淀粉修饰卡介菌多糖核酸口服兽用脂质体及其冻干制剂 Acylation modified amylopectin PSN card veterinary oral and lyophilized preparation of liposomes |
| 02/01/2012 | CN101912609B 防治绿脓杆菌感染的组合物及其制备方法 Pseudomonas aeruginosa infection prevention composition and its preparation method |
| 02/01/2012 | CN101904918B 克咳片及其制备方法 Keke sheet and its preparation method |
| 02/01/2012 | CN101897669B 一种脑靶向递药系统 Kind of brain-targeted drug delivery systems |
| 02/01/2012 | CN101879313B 一种基于树枝状聚合物的抗肿瘤纳米前药系统及其制备方法 An anti-tumor prodrug system and nano-preparation of the dendrimer-based |
| 02/01/2012 | CN101816690B 人参总皂苷双层渗透泵片及其制备方法 TSPG layer osmotic pump tablets and its preparation method |
| 02/01/2012 | CN101816663B 治疗家畜弓形虫病的药物组合物、注射液及其制备方法 Treatment of livestock toxoplasmosis pharmaceutical compositions injection and preparation method |
| 02/01/2012 | CN101798383B 一种聚合物微凝胶及其制备方法 A polymer microgel its preparation method |
| 02/01/2012 | CN101780282B 一种壳聚糖载丝裂霉素纳米靶向制剂及其制备方法 Chitosan contained nano-targeting agents mitomycin and its preparation method |
| 02/01/2012 | CN101745116B 用于治疗威尔森氏症的铜离子螯合吸附介质的制备方法 Preparation for the treatment of Wilson's disease, a copper-chelating adsorption medium |
| 02/01/2012 | CN101732726B 奶牛乳头保护膜成膜剂及其制备方法 Cow Nipple protective film film-forming agent and its preparation method |
| 02/01/2012 | CN101732342B 口服补液盐泡腾片及其应用 Effervescent tablets and oral rehydration salts Applications |
| 02/01/2012 | CN101721372B 金壳包覆的中空介孔二氧化硅球及其制备方法和在肿瘤治疗方面的用途 Hollow mesoporous silica spheres coated with gold shell and its preparation method and use in the treatment of cancer |
| 02/01/2012 | CN101703071B 含分子态二氧化氯的消毒组合物及其应用 Disinfecting compositions containing molecular chlorine dioxide and its application |
| 02/01/2012 | CN101700230B 一种单唾液酸四己糖神经节苷酯微球及其制备方法 A single-sialic four hexose ganglioside microsphere and its preparation method |
| 02/01/2012 | CN101669906B 吡喹酮注射剂及其制备方法和应用 Praziquantel injection and its preparation method and application |
| 02/01/2012 | CN101564667B 一种海藻酸盐软胶囊的制备方法 Method for preparing the soft capsules of alginate |
| 02/01/2012 | CN101439182B 一种生长抑素受体介导的肿瘤靶向药物组合物 One kind of somatostatin receptor-mediated tumor targeting pharmaceutical composition |
| 02/01/2012 | CN101431995B 稳定的维生素c组合物 Stable vitamin c composition |
| 02/01/2012 | CN101129381B 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 Contained within the β- lactam antibiotics and antibiotic ion chelating compound |
| 02/01/2012 | CN101115512B 治疗皮肤病菌特别是甲癣的设备和方法 Especially in the treatment of skin bacteria in the apparatus and method onychomycosis |
| 02/01/2012 | CN101024079B 肺炎链球菌多糖-外膜蛋白结合疫苗及制备方法 Streptococcus pneumoniae polysaccharide - outer membrane protein conjugate vaccine and its preparation method |
| 02/01/2012 | CN101002943B 支链peg-gcsf和peg-gmcsf结合物及其制备方法 Branched peg-gcsf and peg-gmcsf conjugates and its preparation method |
| 01/31/2012 | US8106131 Hydrolytically stable maleimide-terminated polymers |
| 01/31/2012 | US8105630 Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof |
| 01/31/2012 | US8105629 Collagen gel and process of producing the same |
| 01/31/2012 | US8105622 Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| 01/31/2012 | US8105619 Antimicrobial medicotechnical product, process for its production and use |
| 01/31/2012 | US8105617 Cationic copolymers formulated with pigmented cosmetic compositions exhibiting radiance with soft focus |
| 01/31/2012 | US8105608 Method of treatment using ligand-immunogen conjugates |
| 01/31/2012 | US8105570 Methods and compositions for controlled release of drugs |
| 01/31/2012 | US8105391 Merhods of treatment with devices having a coating containing pegylated hyaluronic acid and a pegylated non-hyaluronic acid polymer |
| 01/31/2012 | CA2612128C Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| 01/31/2012 | CA2558233C Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/31/2012 | CA2546476C Pharmaceutical preparation containing gabapentin |
| 01/31/2012 | CA2524907C Polyethylene glycol/polycation block copolymers |
| 01/31/2012 | CA2509449C Lyophilized preparation of stabilized anthracycline compounds |
| 01/31/2012 | CA2493023C Use of alkylphosphocholines in combination with antitumor medicaments |
| 01/31/2012 | CA2443947C Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 01/31/2012 | CA2208790C Adjuvant for vaccines comprising a hydrophobic sulfolipid polysaccharide |
| 01/26/2012 | WO2012012546A2 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 01/26/2012 | WO2012012541A2 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | WO2012012476A1 Pharmaceutical composition with enhanced solubility characteristics |
| 01/26/2012 | WO2012012305A2 Combination therapy using a ruthenium complex |
| 01/26/2012 | WO2012011836A1 The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer |
| 01/26/2012 | WO2012011693A2 Cationic lipid, a production method for the same and a vehicle having cell penetrating properties comprising the same |
| 01/26/2012 | WO2012011566A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | WO2012011429A1 Sheet preparation for tissue adhesion |
| 01/26/2012 | WO2012011192A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | WO2012010883A2 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 01/26/2012 | WO2012010587A1 Sulforaphane stabilization |
| 01/26/2012 | WO2012010562A1 Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile |
| 01/26/2012 | WO2012010561A1 Anti-cd19 antibody having adcc function with improved glycosylation profile |
| 01/26/2012 | WO2012010516A1 Growth hormone conjugates |
| 01/26/2012 | WO2012010478A1 Combination of siloxane and active ingredient for treating dental disorder |
| 01/26/2012 | WO2012010291A1 Diagnostic and therapeutic methods and compositions for metabolic disease |
| 01/26/2012 | WO2012010290A1 Diagnostic and therapeutic methods and compositions for metabolic disease |
| 01/26/2012 | WO2011153400A3 Nasal immunization |
| 01/26/2012 | WO2011152689A9 Method for purifying fucoxanthin derived from seaweed |
| 01/26/2012 | WO2011151786A3 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 01/26/2012 | WO2011135585A3 Aqueous pharmaceutical solution of ciclesonide |
| 01/26/2012 | WO2011106702A3 Sustained delivery of therapeutic agents to an eye compartment |
| 01/26/2012 | WO2011097527A3 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 01/26/2012 | WO2011063775A3 Pectin complexes of sartans and pharmaceutical compositions based thereon |
| 01/26/2012 | WO2011003557A8 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/26/2012 | WO2010143070A3 Amorphous varenicline tartrate co-precipitates |
| 01/26/2012 | US20120022234 Method for the purification of albumin conjugates |
| 01/26/2012 | US20120022170 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 01/26/2012 | US20120022169 Hard capsule |
| 01/26/2012 | US20120022165 Transdermal compositions |
| 01/26/2012 | US20120022159 Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof |
| 01/26/2012 | US20120022037 Aqueous hair cleansing agent |
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120022023 Hydraulic Cements, Methods and Products |
| 01/26/2012 | US20120021053 Controlled release and taste-masking oral pharmaceutical composition |
| 01/26/2012 | US20120021044 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same |
| 01/26/2012 | US20120021021 Method for preparing pharmaceutical compositions comprising fine particles of active substance |
| 01/26/2012 | US20120021020 Branched amphipathic oligo-peptides that self-assemble into vesicles |
| 01/26/2012 | US20120020911 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 01/26/2012 | US20120020887 Use of Simple Amino Acids to Form Porous Particles |
| 01/26/2012 | US20120020882 Peptide-based compounds |
| 01/26/2012 | US20120020878 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| 01/26/2012 | US20120020833 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 01/26/2012 | US20120017924 Coated nicotine-containing chewing gum, manufacture and use thereof |
| 01/26/2012 | CA2806260A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | CA2806076A1 Anti-tumor antigen antibodies and methods of use |
| 01/26/2012 | CA2806058A1 Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | CA2805980A1 Combination of siloxane and active ingredient for treating dental disorder |
| 01/26/2012 | CA2805656A1 Pharmaceutical composition with enhanced solubility characteristics |
| 01/26/2012 | CA2804725A1 Pharmaceutical depot for 5- fluoro-2-[[(1s)-1-(5- fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 01/25/2012 | EP2410031A1 Base material for spraying comprising low-molecular gelling agent |
| 01/25/2012 | EP2409993A1 Anti-CD19 antibody having ADCC function with improved glycosylation profile |
| 01/25/2012 | EP2409712A1 Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile |
| 01/25/2012 | EP2409708A1 Compounds and methods for selectively targeting tumor-associated mucins |